(Press-News.org) Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California.
MSK experts will present significant research and will be available to comment on topics including cancer metastasis, immunology, molecular biology and genetics, and early drug development.
Vinod Balachandran, MD, will present updates on personalized RNA neoantigen vaccines in pancreatic cancer on Sunday, April 7, 2024, from 4:20 PM-4:30 PM PT.
Luis Diaz Jr., MD, will discuss progress in monitoring residual disease (MRD) in solid tumors and how to apply them in the clinic during an educational session on Monday, April 8, 2024, from 4:45 PM-6:15 PM PT.
Dana Pe’er, PhD, will highlight research that sheds new light on the ability of cancer cells to adapt and spread on Tuesday, April 9, 2024, from 8:00AM-10:00 AM PT.
Jonathan Yang, MD, will present data on the safety and preliminary efficacy of AZD1390 + radiation therapy (RT) for glioblastoma (GBM) during a clinical trials minisymposium on Tuesday, April 9, 2024, from 4:05-4:15 PM PT.
Additional highlights include:
Andrew Vickers, PhD, will discuss seven myths about prostate-specific antigen (PSA) testing during an educational session on Saturday, April 6, 2024 from 2:30 PM-4:00 PM PT.
Christine Iacobuzio-Donahue, MD, PhD, will offer insight into profiling tumor ecosystems in native tissue context during the plenary session on Monday, April 8, 2024, from 8:00 AM-10:00 AM PT.
Samuel F. Bakhoum, MD, PhD, will discuss chromosomal instability as a driver of cancer metastasis during a major symposium on Wednesday, April 10, 2024 from 10:15 AM-11:45 AM PT.
Ignacio Vazquez-Garcia, PhD, will offer novel insights into the evolutionary dynamics of whole-genome doubling in ovarian cancer during a major symposium on Tuesday, April 9, 2024, 12:30 PM - 2:00 PM PT.
At the 2024 AACR Annual Meeting, Selwyn M. Vickers, MD, FACS, President & CEO of MSK will be honored during a ceremony recognizing his place among 30 international leaders elected to the prestigious Fellows of the AACR Academy Class of 2024. Dr. Vickers is being recognized for his work characterizing and targeting pancreatic cancer metastasis, development of oncolytic adenoviruses capable of inhibiting pancreas tumor stem cells, and instrumental efforts to develop and evaluate the efficacy of minnelide.
For more information, and to set up interviews, please contact Nick Gardner, Manager, Media Relations at gardnern@mskcc.org. Follow the meeting live on X using the hashtag #AACR24 and follow MSK on X at @MSKCancerCenter.
END
Memorial Sloan Kettering Cancer Center experts to present leading-edge research at the American Association for Cancer Research Annual Meeting 2024
2024-04-01
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Kennedy Krieger publishes major national research and guidance on pediatric autism
2024-04-01
BALTIMORE, April 1, 2024— Researchers at Kennedy Krieger Institute are sharing their expertise on autism spectrum disorder in a medical journal reaching thousands of pediatric professionals worldwide. The journal, Pediatric Clinics, provides the latest clinical information on health and related issues for children and adolescents.
The newly released volume is titled "Pediatric Management of Autism." This issue features five original articles written by 10 faculty members from the Institute. Each contribution investigates crucial aspects of caring for children with autism, offering actionable insights.
Dr. Paul ...
Canada lynx historic range in US likely wider than previously thought
2024-04-01
PULLMAN, Wash. – A broader past could mean a brighter future for Canada lynx in the U.S., according to recent research.
The study, published in the journal Biological Conservation, indicates that lynx might do well in the future in parts of Utah, central Idaho and the Yellowstone National Park region, even considering climate change and the lack of lynx in those areas now.
Using a model validated by historic records, researchers first found that in 1900, Canada lynx had more suitable habitat in the U.S. than the few northern corners of the country where they are found currently. The study showed ...
Study documents safety, improvements from stem cell therapy after spinal cord injury
2024-04-01
ROCHESTER, Minn. — A Mayo Clinic study shows stem cells derived from patients' own fat are safe and may improve sensation and movement after traumatic spinal cord injuries. The findings from the phase 1 clinical trial appear in Nature Communications. The results of this early research offer insights on the potential of cell therapy for people living with spinal cord injuries and paralysis for whom options to improve function are extremely limited.
In the study of 10 adults, the research team noted seven participants demonstrated ...
Simple equations clarify cloud climate conundrum
2024-04-01
New analysis based on simple equations has reduced uncertainty about how clouds will affect future climate change.
Clouds have two main effects on global temperature – cooling the planet by reflecting sunlight, and warming it by acting as insulation for Earth’s radiation.
The impact of clouds is the largest area of uncertainty in global warming predictions.
In the new study, researchers from the University of Exeter and the Laboratoire de Météorologie Dynamique in Paris created a model that predicts how ...
A high-boost and high-efficiency DC power converter
2024-04-01
A new electrical power converter design achieves a much higher efficiency at lower cost and maintenance than before. The direct current voltage boost converter developed by Kobe University is poised to be a significant contribution to the further development of electric and electronic components across power generation, health care, mobility and information technology.
Devices that harvest energy from sunlight or vibrations, or power medical devices or hydrogen-fueled cars have one key component in common. This so-called “boost converter” converts low-voltage direct current input into high-voltage direct current output. Because it is such a ubiquitous ...
Study suggests high blood pressure could begin in childhood
2024-04-01
Study suggests high blood pressure may originate early in life and that preventing overweight and obesity during the developmental years could help reduce the substantial disease burden associated with high blood pressure in later life.
*This is an early press release from the European Congress on Obesity (ECO 2024) Venice 12-15 May. Please credit the Congress if using this material*
Children and teenagers living with overweight or obesity are more likely to have high blood pressure as adults (aged 50-64 years), suggesting the processes behind the condition could begin as early as childhood, suggests new research being ...
Study finds association between TB infection and increased risk of various cancers
2024-04-01
**Note: the release below is a special early release from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, Spain, 27-30 April). Please credit the congress if you use this story**
A population-wide observational study to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows an association between tuberculosis (TB) and cancer, with those with current or previous TB more likely ...
Swedish study indicates a significant decline of neutralising antibodies to monkeypox virus already during the first month after vaccination
2024-03-30
Previous smallpox vaccination contributes significantly to higher neutralising antibodies following first MVA-BN dose
**Note: the release below is a special early release from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, Spain, 27-30 April). Please credit the congress if you use this story**
New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 ...
Study shows Mpox (monkeypox) antibodies wane within a year of vaccination
2024-03-30
New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows that the antibodies produced by Modified Vaccinia virus Ankara - Bavarian Nordic (MVA-BN) vaccination against mpox wane significantly within a year of receiving the vaccination – but in people with pre-existing immunity due to childhood smallpox vaccination in childhood, antibody levels remain high in almost all cases. The study is presented by PhD student Dr. Marc Shamier, Erasmus MC, Rotterdam, Netherlands, from a research team led by Dr Rory de Vries.
During the 2022-2023 ...
Case report from Austria shows mpox breakthrough infection in man who had received both vaccine doses
2024-03-30
New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) details the case of a man who had received two doses of the monkey pox vaccine in Autumn, 2022 yet experienced a ‘breakthrough’ mpox infection in January 2024. The authors believe breakthrough should be considered in fully vaccinated individuals engaging in high-risk behaviors. They also call for further research on the need for booster ...